- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Global Real World Data Tour: 2024 Key Insights
Webinar Date/Time: Wednesday, October 9th, 2024 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Join our webinar to discover the Real World Data needed to generate evidence and answer critical research questions. Gain insights into healthcare systems and unique datasets from North America, Europe, Asia Pacific, and Latin America to understand healthcare trends, treatment approaches, and market dynamics.
Register Free: https://www.pharmexec.com/pe_w/real-world-data-tour
Event Overview:
Calling all Real World Data researchers! Missed the Global Health Data Passport Webinar Series?
Join this webinar to take a data landscape world tour of the 2024 series highlights. Explore unique datasets from each region, covering key therapeutic areas, to gain faster insights into healthcare trends, treatment approaches, and market dynamics. Discover the Real World Data sources you need to generate evidence and answer critical research questions.
Three key take-aways
- Gain insights into healthcare systems and available data assets from countries throughout North America, Europe, Asia Pacific, and Latin America.
- Learn how to streamline multi-country studies by leveraging a common data model for rapid comparative analyses across diverse countries and datasets
- Discover how to rapidly identify data and accelerate your analysis with AI, machine learning, and data linking to visualize the full patient journey
Speakers
Megan Califano
Director, Offering Management
IQVIA USA
Alan Thomas
Senior Director, Strategic Planning
IQVIA Japan
Paul Berg
Senior Principal, Real World Solutions
IQVIA UK
Ramon Pereira
Head of Data Science
IQVIA Brazil & LATAM
Ken Chin
Senior Consultant
IQVIA Australia
Long Pang
Engagement Manager
Real World Solutions, IQVIA
China
Andrzej Mazurek
Engagement Manager
IQVIA Poland
Sarah Seager
Senior Director, Analytics & AI
IQVIA Global
Register Free: https://www.pharmexec.com/pe_w/real-world-data-tour
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Cell and Gene Therapy Check-in 2024
January 18th 2024Fran Gregory, VP of Emerging Therapies, Cardinal Health discusses her career, how both CAR-T therapies and personalization have been gaining momentum and what kind of progress we expect to see from them, some of the biggest hurdles facing their section of the industry, the importance of patient advocacy and so much more.
ROI and Rare Disease: Retooling the ‘Gene’ Value Machine
November 14th 2024Framework proposes three strategies designed to address the unique challenges of personalized and genetic therapies for rare diseases—and increase the probability of economic success for a new wave of potential curative treatments for these conditions.
Tirzepatide Demonstrates Significant Benefits for Patients with Pre-Diabetes, Obesity Over 176 Weeks
November 14th 2024Results from the Phase III SURMOUNT-1 study show that tirzepatide, a dual GIP and GLP-1 receptor agonist, achieved substantial average weight loss of 22.9% in patients with pre-diabetes and obesity.
